BCD-236
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCD-236, covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer [Phase 2]